News

Filter

Current filters:

EisaiNeurological

1 to 9 of 87 results

Eisai launches epilepsy treatment Exalief in Russia

Eisai launches epilepsy treatment Exalief in Russia

20-01-2015

Japanese drug major Eisai has announced that epilepsy drug Exalief (eslicarbazepine acetate) will soon…

EisaiExaliefMarkets & MarketingNeurologicalPharmaceuticalRussia

Eisai's Fycompa for refractory partial-onset seizures meets Phase III trial primary endpoint

Eisai's Fycompa for refractory partial-onset seizures meets Phase III trial primary endpoint

05-01-2015

Japanese drug major Eisai has announced a Phase III trial of antiepileptic drug Fycompa (perampanel)…

EisaiFycompaJapanNeurologicalperampanelPharmaceuticalResearch

Eisai opens new parenteral facility in China

29-11-2014

Japanese pharma major Eisai (TYO: 4523) said on Friday that construction of a new production facility…

ChinaEisaiMethycobalNeurologicalPharmaceuticalProduction

Eisai’s Zonegran safety in pediatric patients confirmed by pooled data analysis

Eisai’s Zonegran safety in pediatric patients confirmed by pooled data analysis

10-11-2014

The safety profile of adjunctive Japanese drugmaker Eisai’s Zonegran (zonisamide) in pediatric patients…

EisaiEuropeNeurologicalPharmaceuticalResearchZonegran

Eisai “dismayed” by G-BA decision on Fycompa

06-11-2014

Japanese drug major Eisai has expressed “utmost disappointment” that the German Federal Joint Committee…

EisaiFycompaGermanyNeurologicalPharmaceuticalPricingRegulation

Eisai's Fycompa launches in Australia for seizures

Eisai's Fycompa launches in Australia for seizures

03-11-2014

Fycompa (perampanel), manufactured by Japanese drug major Eisai, has been approved for reimbursement…

AustraliaEisaiFycompaNeurologicalPharmaceuticalRegulation

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

15-10-2014

There was good news for Japanese drugmaker Eisai yesterday, as the US Food and Drug Administration granted…

BanzelEisailenvatinibNeurologicalOncologyPharmaceuticalRegulationRufinamide TabletsUSA

Hikma to distribute Eisai’s Fycompa in Middle East

13-10-2014

Hikma Pharmaceuticals has entered into a partnership with Japanese pharma major Eisai for the distribution…

EisaiFycompaHikma PharmaceuticalsJordanLicensingMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldSaudi Arabia

1 to 9 of 87 results

COMPANY SPOTLIGHT

Menarini

Back to top